Merck may be on to a winning therapy targeting the lowering of bad cholesterol. Still in the early stages, two recent clinical trials evidence that…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.